Related Experiment Videos
Disturbances in toxicological experiments caused by Microsporum canis
Mycopathologia
|August 1, 1985
Abstract:
Cutaneous lesions which can lead to false positive results have been observed in several rabbits used for the determination of the cutaneous irritation capacity of a product (ITA, PII). The responsible agent was Microsporum canis. A preventive treatment by an antifungal agent did not modify toxicological experimental results.
Insights
Fungal infections in rabbits caused false positive results during skin irritation tests. Antifungal treatments did not alter these toxicological outcomes, highlighting a challenge in product safety testing.
Area of Science:
- Veterinary dermatology
- Toxicology
- Dermatophytosis
Background:
- Cutaneous irritation testing in rabbits is crucial for product safety assessment.
- Unforeseen factors can compromise the reliability of toxicological data.
- Microsporum canis is a known dermatophyte affecting various animal species.
Purpose of the Study:
- To identify the cause of false positive results in rabbit skin irritation tests.
- To evaluate the impact of fungal infection on toxicological assessments.
- To determine the efficacy of antifungal treatment in mitigating test interferences.
Main Methods:
- Observation of cutaneous lesions in rabbits undergoing skin irritation tests (In Vivo Toxicology Assay, Product Information Investigation).
- Identification of the causative agent through microbiological analysis.
- Administration of a preventive antifungal treatment to a subset of rabbits.
- Comparison of toxicological results between infected and treated groups.
Main Results:
- Cutaneous lesions, attributed to Microsporum canis infection, were observed in rabbits.
- The presence of fungal lesions led to false positive outcomes in skin irritation assessments.
- Preventive antifungal treatment did not significantly alter the toxicological experimental results.
Conclusions:
- Microsporum canis infections can confound skin irritation tests in rabbits, leading to inaccurate safety assessments.
- Standard toxicological testing protocols may not adequately account for subclinical or overt dermatophyte infections.
- Further investigation into managing or preventing such infections is warranted to ensure the integrity of product safety evaluations.